Global Percutaneous Transluminal Angioplasty Balloons Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Percutaneous Transluminal Angioplasty Balloons Market Research Report 2024
Percutaneous Transluminal Angioplasty (PTA) is a minimally invasive medical procedure used for the treatment of various cardiovascular diseases such as atherosclerosis, peripheral artery disease, and coronary artery disease. PTA balloons are employed to widen or dilate narrowed or blocked blood vessels, thus allowing for better blood flow.
According to Mr Accuracy reports’s new survey, global Percutaneous Transluminal Angioplasty Balloons market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Percutaneous Transluminal Angioplasty Balloons market research.
Key manufacturers engaged in the Percutaneous Transluminal Angioplasty Balloons industry include Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis, Medtronic, MicroPort Scientific Corporation, Opto Circuits (India) Ltd. and Spectranetics (Philips Healthcare), etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Percutaneous Transluminal Angioplasty Balloons were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Percutaneous Transluminal Angioplasty Balloons market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Percutaneous Transluminal Angioplasty Balloons market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott
B. Braun Melsungen AG
Boston Scientific Corporation
Cook Medical
Cordis
Medtronic
MicroPort Scientific Corporation
Opto Circuits (India) Ltd.
Spectranetics (Philips Healthcare)
Terumo Corporation
Segment by Type
Conventional Balloons
Drug Eluting Balloons
Cutting and Scoring Balloons
Coronary Angioplasty
Peripheral Angioplasty
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Percutaneous Transluminal Angioplasty Balloons report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Percutaneous Transluminal Angioplasty Balloons market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Percutaneous Transluminal Angioplasty Balloons market research.
Key manufacturers engaged in the Percutaneous Transluminal Angioplasty Balloons industry include Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis, Medtronic, MicroPort Scientific Corporation, Opto Circuits (India) Ltd. and Spectranetics (Philips Healthcare), etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Percutaneous Transluminal Angioplasty Balloons were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Percutaneous Transluminal Angioplasty Balloons market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Percutaneous Transluminal Angioplasty Balloons market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
B. Braun Melsungen AG
Boston Scientific Corporation
Cook Medical
Cordis
Medtronic
MicroPort Scientific Corporation
Opto Circuits (India) Ltd.
Spectranetics (Philips Healthcare)
Terumo Corporation
Segment by Type
Conventional Balloons
Drug Eluting Balloons
Cutting and Scoring Balloons
Segment by Application
Coronary Angioplasty
Peripheral Angioplasty
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Percutaneous Transluminal Angioplasty Balloons report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source